{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T23:40:49Z","timestamp":1767138049235,"version":"build-2238731810"},"publisher-location":"Berlin, Heidelberg","reference-count":68,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642335693","type":"print"},{"value":"9783642335709","type":"electronic"}],"license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/978-3-642-33570-9_10","type":"book-chapter","created":{"date-parts":[[2012,12,13]],"date-time":"2012-12-13T07:31:22Z","timestamp":1355383882000},"page":"197-218","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Structure-Based Drug Discovery for Botulinum Neurotoxins"],"prefix":"10.1007","author":[{"given":"Subramanyam","family":"Swaminathan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,14]]},"reference":[{"key":"10_CR1","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0014-5793(98)00492-X","volume":"429","author":"M Adler","year":"1998","unstructured":"Adler M, Nicholson JD, Hackley BE (1998) Efficacy of a novel metalloprotease inhibitor on botulinum neurotoxin B activity. FEBS Lett 429:234\u2013238","journal-title":"FEBS Lett"},{"key":"10_CR2","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1002\/(SICI)1099-1263(199912)19:1+<S5::AID-JAT606>3.0.CO;2-M","volume":"19","author":"M Adler","year":"1999","unstructured":"Adler M, Nicholson JD, Starks DF, Kane CT, Cornille F, Hackley BE (1999) Evaluation of phosphoramidon and three synthetic phosphonates for inhibition of botulinum neurotoxin B catalytic activity. J Appl Toxicol 19:S5\u2013S11","journal-title":"J Appl Toxicol"},{"key":"10_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/82_2010_91","volume":"348","author":"MJ Adler","year":"2011","unstructured":"Adler MJ, Jamieson AG, Hamilton AD (2011) Hydrogen-bonded synthetic mimics of protein secondary structure as disruptors of protein\u2013protein interactions. Curr Top Microbiol Immunol 348:1\u201323","journal-title":"Curr Top Microbiol Immunol"},{"key":"10_CR4","doi-asserted-by":"publisher","first-page":"8291","DOI":"10.1021\/bi050253a","volume":"44","author":"R Agarwal","year":"2005","unstructured":"Agarwal R, Binz T, Swaminathan S (2005a) Analysis of active site residues of botulinum neurotoxin E by mutational, functional and structural studies: Glu335Gln is an apoenzyme. Biochemistry 44:8291\u20138302","journal-title":"Biochemistry"},{"key":"10_CR5","doi-asserted-by":"publisher","first-page":"11758","DOI":"10.1021\/bi0510072","volume":"44","author":"R Agarwal","year":"2005","unstructured":"Agarwal R, Binz T, Swaminathan S (2005b) Structural analysis of botulinum neurotoxin serotype f light chain: implications on substrate binding and inhibitor design. Biochemistry 44:11758\u201311765","journal-title":"Biochemistry"},{"key":"10_CR6","doi-asserted-by":"publisher","first-page":"6637","DOI":"10.1021\/bi036278w","volume":"43","author":"R Agarwal","year":"2004","unstructured":"Agarwal R, Eswaramoorthy S, Kumaran D, Binz T, Swaminathan S (2004) Structural analysis of botulinum neurotoxin type E catalytic domain and its mutant Glu212->Gln reveals the pivotal role of the Glu212 carboxylate in the catalytic pathway. Biochemistry 43:6637\u20136644","journal-title":"Biochemistry"},{"key":"10_CR7","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nsmb.1626","volume":"16","author":"R Agarwal","year":"2009","unstructured":"Agarwal R, Schmidt JJ, Stafford RG, Swaminathan S (2009) Mode of VAMP substrate recognition and inhibition of Clostridium botulinum neurotoxin F. Nat Struct Mol Biol 16:789\u2013794","journal-title":"Nat Struct Mol Biol"},{"key":"10_CR8","doi-asserted-by":"publisher","first-page":"25944","DOI":"10.1074\/jbc.M803756200","volume":"283","author":"R Agarwal","year":"2008","unstructured":"Agarwal R, Swaminathan S (2008) SNAP-25 substrate peptide (residues 180\u2013183) binds to but bypasses cleavage by catalytically active Clostridium botulinum neurotoxin E. J Biol Chem 283:25944\u201325951","journal-title":"J Biol Chem"},{"key":"10_CR9","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/cbic.200400398","volume":"8","author":"C Anne","year":"2005","unstructured":"Anne C, Turcaud S, Blommaert AG, Darchen F, Johnson EA, Roques BP (2005) Partial protection against Botulinum B neurotoxin-induced blocking of exocytosis by a potent inhibitor of its metallopeptidase activity. Chem Bio Chem 8:1375\u20131380","journal-title":"Chem Bio Chem"},{"key":"10_CR10","doi-asserted-by":"publisher","first-page":"4648","DOI":"10.1021\/jm0300680","volume":"46","author":"C Anne","year":"2003","unstructured":"Anne C, Turcaud S, Quancard J, Teffo F, Meudal H, Fournie-Zaluski M-C, Roques BP (2003) Development of potent inhibitors of botulinum neurotoxin type B. J Med Chem 46:4648\u20134656","journal-title":"J Med Chem"},{"key":"10_CR11","first-page":"3255","volume":"45","author":"JW Arndt","year":"2006","unstructured":"Arndt JW, Chai Q, Christian T, Stevens RC (2006) Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity. Biochem Cell Biol 45:3255\u20133262","journal-title":"Biochem Cell Biol"},{"key":"10_CR12","doi-asserted-by":"publisher","first-page":"9574","DOI":"10.1021\/bi0505924","volume":"44","author":"JW Arndt","year":"2005","unstructured":"Arndt JW, Yu W, Bi F, Stevens RC (2005) Crystal structure of botulinum neurotoxin type G light chain: serotype divergence in substrate recognition. Biochemistry 44:9574\u20139580","journal-title":"Biochemistry"},{"key":"10_CR13","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1021\/bi0157969","volume":"41","author":"T Binz","year":"2002","unstructured":"Binz T, Bade S, Rummel A, Kollewe A, Alves J (2002) Arg362 and Tyr365 of the botulinum neurotoxin type A light chain are involved in transition state stabilization. Biochemistry 41:1717\u20131723","journal-title":"Biochemistry"},{"key":"10_CR14","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1039\/b603099h","volume":"7","author":"GE Boldt","year":"2006","unstructured":"Boldt GE, Eubanks LM, Janda KD (2006a) Identification of a botulinum neurotoxin A protease inhibitor displaying efficacy in a cellular model. Chem Commun 7:3063\u20133065","journal-title":"Chem Commun"},{"key":"10_CR15","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1021\/cc060010h","volume":"8","author":"GE Boldt","year":"2006","unstructured":"Boldt GE, Kennedy JP, Hixon MS, McAllister LA, Barbieri JT, Tzipori S, Janda KD (2006b) Synthesis, characterization and development of a high-throughput methodology for the discovery of botulinum neurotoxin A inhibitors. J Comb Chem 8:513\u2013521","journal-title":"J Comb Chem"},{"key":"10_CR16","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/nature03123","volume":"432","author":"MA Breidenbach","year":"2004","unstructured":"Breidenbach MA, Brunger A (2004) Substrate recognition strategy for botulinum neurotoxin serotype A. Nature 432:925\u2013929","journal-title":"Nature"},{"key":"10_CR17","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.1021\/ol026590i","volume":"4","author":"M Brewer","year":"2002","unstructured":"Brewer M, Oost T, Sukonpan C, Pereckas M, Rich DH (2002) Sequencing hydroxyethylamine-containing peptides via Edman degradation. Org Lett 4:3469\u20133472","journal-title":"Org Lett"},{"key":"10_CR18","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1371\/journal.ppat.0030113","volume":"3","author":"AT Brunger","year":"2007","unstructured":"Brunger AT, Breidenbach MA, Jin R, Fischer A, Santos JS, Montal M (2007) Botulinum neurotoxin heavy chain belt as an intramolecular chaperone for the light chain. PLoS Pathog 3:1191\u20131194","journal-title":"PLoS Pathog"},{"key":"10_CR19","doi-asserted-by":"publisher","first-page":"5004","DOI":"10.1074\/jbc.M608166200","volume":"282","author":"JC Burnett","year":"2007","unstructured":"Burnett JC, Ruthel G, Stegmann CM, Panchal RG, Nguyen TL, Hermone AR, Stafford RG, Lane DJ, Kenny TA, McGrath CF, Wipf P, Stahl AM, Schmidt JJ, Gussio R, Brunger AT, Bavari S (2007) Inhibition of metalloprotease botulinum serotype A from a pseudo-peptide binding mode to a small molecule that is active in primary neurons. J Biol Chem 282:5004\u20135014","journal-title":"J Biol Chem"},{"key":"10_CR20","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1039\/b808305c","volume":"30","author":"K Capkova","year":"2008","unstructured":"Capkova K, Hixon MS, McAllister LA, Janda KD (2008) Toward the discovery of potent inhibitors of botulinum neurotoxin A: development of a robust LC MS based assay operational from low to subnanomolar enzyme concentrations. Chem Commun (Camb) 30:3525\u20133527","journal-title":"Chem Commun (Camb)"},{"key":"10_CR21","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bmcl.2009.10.129","volume":"20","author":"K Capkova","year":"2010","unstructured":"Capkova K, Hixon MS, Pellett S, Barbieri JT, Johnson EA, Janda KD (2010) Benzylidene cyclopentenediones: First irreversible inhibitors against botulinum neurotoxin A\u2019s zinc endopeptidase. Bioorg Med Chem Lett 20:206\u2013208","journal-title":"Bioorg Med Chem Lett"},{"key":"10_CR22","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.toxicon.2009.03.016","volume":"54","author":"K Capkova","year":"2009","unstructured":"Capkova K, Salzameda NT, Janda KD (2009) Investigations into small molecule non-peptidic inhibitors of the botulinum neurotoxins. Toxicon 54:575\u2013582","journal-title":"Toxicon"},{"key":"10_CR23","doi-asserted-by":"publisher","first-page":"6463","DOI":"10.1016\/j.bmcl.2007.09.103","volume":"17","author":"K Capkova","year":"2007","unstructured":"Capkova K, Yoneda Y, Dickerson TJ, Janda KD (2007) Synthesis and structure-activity relationships of second-generation hydroxamate botulinum neurotoxin A protease inhibitors. Bioorg Med Chem Lett 17:6463\u20136466","journal-title":"Bioorg Med Chem Lett"},{"key":"10_CR24","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/nature05411","volume":"444","author":"Q Chai","year":"2006","unstructured":"Chai Q, Arndt JW, Dong M, Tepp WH, Johnson EA, Chapmann ER, Stevens RC (2006) Structural basis of cell surface receptor recognition by botulinum neurotoxin B. Nature (London), New Biology 444:1019\u20131020","journal-title":"Nature (London), New Biology"},{"key":"10_CR25","doi-asserted-by":"publisher","first-page":"10906","DOI":"10.1074\/jbc.M513032200","volume":"281","author":"S Chen","year":"2006","unstructured":"Chen S, Barbieri JT (2006) Unique substrate recognition by botulinum neurotoxins serotypes A and E. J Biol Chem 281:10906\u201310911","journal-title":"J Biol Chem"},{"key":"10_CR26","doi-asserted-by":"publisher","first-page":"25540","DOI":"10.1074\/jbc.M701922200","volume":"282","author":"S Chen","year":"2007","unstructured":"Chen S, Barbieri JT (2007) Multiple pocket recognition of SNAP25 by botulinum neurotoxin serotype E. J Biol Chem 282:25540\u201325547","journal-title":"J Biol Chem"},{"key":"10_CR27","doi-asserted-by":"publisher","first-page":"29604","DOI":"10.1074\/jbc.M703619200","volume":"282","author":"A Fischer","year":"2007","unstructured":"Fischer A, Montal M (2007) Crucial role of the disulfide bridge between botulinum neurotoxin light and heavy chains in protease translocation across membranes. J Biol Chem 282:29604\u201329611","journal-title":"J Biol Chem"},{"key":"10_CR28","doi-asserted-by":"publisher","first-page":"e1000245","DOI":"10.1371\/journal.ppat.1000245","volume":"4","author":"A Fischer","year":"2008","unstructured":"Fischer A, Mushrush DJ, Lacy DB, Montal M (2008) Botulinum neurotoxin devoid of receptor binding domain translocates active protease. PLoS Pathog 4:e1000245","journal-title":"PLoS Pathog"},{"key":"10_CR29","doi-asserted-by":"publisher","first-page":"27668","DOI":"10.1074\/jbc.M802557200","volume":"283","author":"M Galloux","year":"2008","unstructured":"Galloux M, Vitrac H, Montagner C, Raffestin S, Popoff MR, Chenal A, Forge V, Gillet D (2008) Membrane Interaction of botulinum neurotoxin A translocation (T) domain. The belt region is a regulatory loop for membrane interaction. J Biol Chem 283:27668\u201327676","journal-title":"J Biol Chem"},{"key":"10_CR30","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1074\/jbc.M110.146464","volume":"286","author":"M Hale","year":"2010","unstructured":"Hale M, Oyler G, Swaminathan S, Ahmed SA (2010) Basic tetrapeptides as potent intracellular inhibitors of type A botulinum neurotoxin protease activity. J Biol Chem 286:1802\u20131811","journal-title":"J Biol Chem"},{"key":"10_CR31","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/cmdc.200800241","volume":"3","author":"AR Hermone","year":"2008","unstructured":"Hermone AR, Burnett JC, Nuss JE, Tressler LE, Nguyen TL, Solaja BA, Vennerstorm JL, Schmidt JJ, Wipf P, Bavari S, Gussio R (2008) Three-Dimensional Database Mining Identifies a Unique Chemotype that Unites Structurally Diverse Botulinum Neurotoxin Serotype A Inhibitors in a Three-Zone Pharmacophore. Chem Med Chem 3:1905\u20131912","journal-title":"Chem Med Chem"},{"key":"10_CR32","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/nature05387","volume":"444","author":"R Jin","year":"2006","unstructured":"Jin R, Rummel A, Binz T, Brunger AT (2006) Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity. Nature (London) New Biology 444:1092\u20131095","journal-title":"Nature (London) New Biology"},{"key":"10_CR33","doi-asserted-by":"publisher","first-page":"10685","DOI":"10.1021\/bi701162d","volume":"46","author":"R Jin","year":"2007","unstructured":"Jin R, Sikorra S, Stegmann CM, Pich A, Binz T, Brunger AT (2007) Structural and biochemical studies of botulinum neurotoxin serotype C1 light chain protease: implications for dual substrate specificity. Biochemistry 46:10685\u201310693","journal-title":"Biochemistry"},{"key":"10_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nsb879","volume":"10","author":"L Koriazova","year":"2003","unstructured":"Koriazova L, Montal M (2003) Translocation of botulinum neurotoxin light chain protease through the heavy chain channel. Nat Struct Biol 10:13\u201318","journal-title":"Nat Struct Biol"},{"key":"10_CR35","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1039\/c2cc17158a","volume":"48","author":"G Kumar","year":"2012","unstructured":"Kumar G, Agarwal R, Swaminathan S (2012a) Discovery of a fluorene class of compounds as inhibitors of botulinum neurotoxin serotype E by virtual screening. Chem Commun (Camb) 48:2412\u20132414","journal-title":"Chem Commun (Camb)"},{"key":"10_CR36","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1107\/S0907444912003551","volume":"68","author":"G Kumar","year":"2012","unstructured":"Kumar G, Kumaran D, Ahmed SA, Swaminathan S (2012b) Peptide inhibitors of botulinum neurotoxin serotype A: design, inhibition, co crystal structures, structure-activity relationship and pharmacophore modeling. Acta Crystallogr D Biol Crystallogr 68:511\u2013520","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10_CR37","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jmb.2008.12.027","volume":"386","author":"D Kumaran","year":"2009","unstructured":"Kumaran D, Eswaramoorthy S, Furey W, Navaza J, Sax M, Swaminathan S (2009) Domain organization in Clostridium botulinum neurotoxin type E is unique: Its implication in faster translocation. J Mol Biol 386:233\u2013245","journal-title":"J Mol Biol"},{"key":"10_CR38","doi-asserted-by":"publisher","first-page":"e1000165","DOI":"10.1371\/journal.ppat.1000165","volume":"4","author":"D Kumaran","year":"2008","unstructured":"Kumaran D, Rawat R, Ahmed SA, Swaminathan S (2008a) Substrate binding mode and its implication on drug design for botulinum neurotoxin A. PLoS Pathog 4:e1000165","journal-title":"PLoS Pathog"},{"key":"10_CR39","doi-asserted-by":"publisher","first-page":"18883","DOI":"10.1074\/jbc.M801240200","volume":"283","author":"D Kumaran","year":"2008","unstructured":"Kumaran D, Rawat R, Ludivico ML, Ahmed SA, Swaminathan S (2008b) Structure and substrate based inhibitor design for clostridium botulinum neurotoxin serotype A. J Biol Chem 283:18883\u201318891","journal-title":"J Biol Chem"},{"key":"10_CR40","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/2338","volume":"5","author":"DB Lacy","year":"1998","unstructured":"Lacy DB, Tepp W, Cohen AC, DasGupta BR, Stevens RC (1998) Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat Struct Biol 5:898\u2013902","journal-title":"Nat Struct Biol"},{"key":"10_CR41","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1021\/bi992321x","volume":"39","author":"L Li","year":"2000","unstructured":"Li L, Binz T, Niemann H, Singh BR (2000) Probing the mechanistic role of glutamate residues in the zinc-binding motif of type A botulinum neurotoxin light chain. Biochemistry 39:2399\u20132405","journal-title":"Biochemistry"},{"key":"10_CR42","doi-asserted-by":"crossref","unstructured":"Li Y, Foran P, Fairweather NF, Paiva Ad, Weller U, Dougan G, Dolly JO (1994) A single mutation in the recombinant light chain of tetanus toxin abolishes its proteolytic activity and removes the toxicity seen after reconstitution with native heavy chain. Biochemistry 33:7014\u20137020","DOI":"10.1021\/bi00188a034"},{"key":"10_CR43","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1021\/jm981066w","volume":"42","author":"L Martin","year":"1999","unstructured":"Martin L, Cornille F, Turcaud S, Meudal H, Roques BP, Fourine-Zaluski MC (1999) Metallopeptidase inhibitors of tetanus toxin: a combinatorial approach. J Med Chem 42:515\u2013525","journal-title":"J Med Chem"},{"key":"10_CR44","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.bbrc.2009.02.003","volume":"381","author":"G Masuyer","year":"2009","unstructured":"Masuyer G, Thiyagarajan N, James PL, Marks PHH, Chaddock J, Acharya KR (2009) Crystal structure of a catalytically active, non-toxic endopeptidase derivative of Clostridium botulinum toxin A. Biochem Biophys Res Commun 381:50\u201353","journal-title":"Biochem Biophys Res Commun"},{"key":"10_CR45","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1021\/ar00153a003","volume":"21","author":"BW Matthews","year":"1988","unstructured":"Matthews BW (1988) Structural basis of the action of thermolysin and related zinc peptides. Acc Chem Res 21:333\u2013340","journal-title":"Acc Chem Res"},{"key":"10_CR46","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.toxicon.2008.11.018","volume":"54","author":"M Montal","year":"2009","unstructured":"Montal M (2009) Translocation of botulinum neurotoxin light chain protease by the heavy chain protein-conducting channel. Toxicon 54:565\u2013569","journal-title":"Toxicon"},{"key":"10_CR47","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/0014-5793(94)00449-8","volume":"346","author":"C Montecucco","year":"1994","unstructured":"Montecucco C, Papini E, Schiavo G (1994) Bacterial protein toxins penetrate cells via a four-step mechanism. FEBS Lett 346:92\u201398","journal-title":"FEBS Lett"},{"key":"10_CR48","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1002\/bip.10590","volume":"71","author":"T Oost","year":"2003","unstructured":"Oost T, Sukonpan C, Brewer M, Goodnough M, Tepp W, Johnson EA, Rich DH (2003) Design and synthesis of substrate-based inhibitors of botulinum neurotoxin type B metalloprotease. Biopolymers 71:602\u2013619","journal-title":"Biopolymers"},{"key":"10_CR49","doi-asserted-by":"publisher","first-page":"e10129","DOI":"10.1371\/journal.pone.0010129","volume":"5","author":"YP Pang","year":"2010","unstructured":"Pang YP, Davis J, Wang S, Park JG, Nambiar MP, Schmidt JJ, Millard CB (2010a) Small molecules showing significant protection of mice against botulinum neurotoxin serotype A. PLoS ONE 5:e10129","journal-title":"PLoS ONE"},{"key":"10_CR50","doi-asserted-by":"publisher","first-page":"e7730","DOI":"10.1371\/journal.pone.0007730","volume":"4","author":"YP Pang","year":"2009","unstructured":"Pang YP, Vummenthala A, Mishra RK, Park JG, Wang S, Davis J, Millard CB, Schmidt JJ (2009) Potent new small-molecule inhibitor of botulinum neurotoxin serotype A endopeptidase developed by synthesis-based computer-aided molecular design. PLoS ONE 4:e7730","journal-title":"PLoS ONE"},{"key":"10_CR51","doi-asserted-by":"publisher","first-page":"e7730","DOI":"10.1371\/journal.pone.0007730","volume":"4","author":"YP Pang","year":"2010","unstructured":"Pang YP, Vummenthala A, Mishra RK, Park JG, Wang S, Davis J, Millard CB, Schmidt JJ (2010b) Potent new small-molecule inhibitor of botulinum neurotoxin serotype A endopeptidase developed by synthesis-based computer-aided molecular design. PLoS ONE 4:e7730","journal-title":"PLoS ONE"},{"key":"10_CR52","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1073\/pnas.0609713104","volume":"104","author":"A Rummel","year":"2007","unstructured":"Rummel A, Eichner T, Weil T, Karnath T, Gutcaits A, Mahrhold S, Sandhoff K, Proia RL, Acharya KR, Bigalke H, Binz T (2007) Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept. Proc Natl Acad Sci USA 104:359\u2013364","journal-title":"Proc Natl Acad Sci USA"},{"key":"10_CR53","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1039\/c0cc04078a","volume":"47","author":"NT Salzameda","year":"2011","unstructured":"Salzameda NT, Eubanks ME, Zakhari JS, Tsuchikama K, DeNunzio NJ, Allen KA, Hixon SS, Janda KD (2011) A cross-over inhibitor of the botulinum neurotoxin light chain B: a natural product implicating an exosite mechanism of action. Chem Commun 47:1713\u20131715","journal-title":"Chem Commun"},{"key":"10_CR54","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1152\/physrev.2000.80.2.717","volume":"80","author":"G Schiavo","year":"2000","unstructured":"Schiavo G, Matteoli M, Montecucco C (2000) Neurotoxins affecting neuroexocytosis. Physiol Rev 80:717\u2013766","journal-title":"Physiol Rev"},{"key":"10_CR55","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0014-5793(02)03738-9","volume":"532","author":"JJ Schmidt","year":"2002","unstructured":"Schmidt JJ, Stafford RG (2002) A high-affinity competitive inhibitor of type A botulinum neurotoxin protease activity. FEBS Lett 532:423\u2013426","journal-title":"FEBS Lett"},{"key":"10_CR56","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1021\/bi0477642","volume":"44","author":"JJ Schmidt","year":"2005","unstructured":"Schmidt JJ, Stafford RG (2005) Botulinum neurotoxin serotype F: identification of substrate recognition requirements and development of inhibitors with low nanomolar affinity. Biochemistry 44:4067\u20134073","journal-title":"Biochemistry"},{"key":"10_CR57","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0014-5793(98)01041-2","volume":"435","author":"JJ Schmidt","year":"1998","unstructured":"Schmidt JJ, Stafford RG, Bostian KA (1998) Type A botulinum neurotoxin proteolytic activity: development of competitive inhibitors and implications for substrate specificity at the S1\u2019 binding subsite. FEBS Lett 435:61\u201364","journal-title":"FEBS Lett"},{"key":"10_CR58","doi-asserted-by":"publisher","first-page":"21145","DOI":"10.1074\/jbc.M800610200","volume":"283","author":"S Sikorra","year":"2008","unstructured":"Sikorra S, Henke T, Galli T, Binz T (2008) Substrate recognition mechanism of VAMP\/synaptobrevin-cleaving clostridial neurotoxins. J Biol Chem 283:21145\u201321152","journal-title":"J Biol Chem"},{"key":"10_CR59","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1021\/ja910761y","volume":"132","author":"P Silh\u00e1r","year":"2010","unstructured":"Silh\u00e1r P, Capkov\u00e1 K, Salzameda NT, Barbieri JT, Hixon MS, Janda KD (2010) Botulinum neurotoxin A protease: discovery of natural product exosite inhibitors. J Am Chem Soc 132:2868\u20132869","journal-title":"J Am Chem Soc"},{"key":"10_CR60","doi-asserted-by":"publisher","first-page":"5736","DOI":"10.1021\/bi8001067","volume":"47","author":"NR Silvaggi","year":"2008","unstructured":"Silvaggi NR, Wilson D, Tzipori S, Allen KN (2008) Catalytic features of the botulinum neurotoxin a light chain revealed by high resolution structure of an inhibitory peptide complex. Biochemistry 47:5736\u20135745","journal-title":"Biochemistry"},{"key":"10_CR61","doi-asserted-by":"publisher","first-page":"e1000129","DOI":"10.1371\/journal.ppat.1000129","volume":"4","author":"P Stenmark","year":"2008","unstructured":"Stenmark P, Dupuy J, Imamura A, Kiso M, Stevens RC (2008) Crystal structure of botulinum neurotoxin type A in complex with the cell surface co-receptor GT1b-insight into the toxin-neuron interaction. PLoS Pathog 4:e1000129","journal-title":"PLoS Pathog"},{"key":"10_CR62","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1399-3011.2004.00124.x","volume":"63","author":"C Sukonpan","year":"2004","unstructured":"Sukonpan C, Oost T, Goodnough M, Tepp W, Johnson EA, Rich DH (2004) Synthesis of substrates and inhibitors of botulinum neurotoxin type A metalloprotease. J Pept Res 63:181\u2013193","journal-title":"J Pept Res"},{"key":"10_CR63","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/78005","volume":"7","author":"S Swaminathan","year":"2000","unstructured":"Swaminathan S, Eswaramoorthy S (2000) Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B. Nat Struct Biol 7:693\u2013699","journal-title":"Nat Struct Biol"},{"issue":"8","key":"10_CR64","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1002\/mds.20005","volume":"19","author":"S Swaminathan","year":"2004","unstructured":"Swaminathan S, Eswaramoorthy S, Kumaran D (2004) Structure and enzymatic activity of botulinum neurotoxins. Movement Disord 19(8):S17\u2013S22","journal-title":"Movement Disord"},{"key":"10_CR65","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.1021\/bi2001483","volume":"50","author":"AA Thompson","year":"2011","unstructured":"Thompson AA, Jiao GS, Kim S, Thai A, Cregar-Hernandez L, Margosiak SA, Johnson AT, Han GW, O\u2019Malley S, Stevens RC (2011) Structural characterization of three novel hydroxamate-based zinc chelating inhibitors of the Clostridium botulinum serotype A neurotoxin light chain metalloprotease reveals a compact binding site resulting from 60\/70\u00a0loop flexibility. Biochemistry 50:4019\u20134028","journal-title":"Biochemistry"},{"key":"10_CR66","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1046\/j.1471-4159.1999.0720327.x","volume":"72","author":"VV Vaidyanathan","year":"1999","unstructured":"Vaidyanathan VV, Yoshino K, Jahnz M, Dorries C, Bade S, Nauenburg S, Niemann H, Binz T (1999) Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: Domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage. J Neurochem 72:327\u2013337","journal-title":"J Neurochem"},{"key":"10_CR67","doi-asserted-by":"publisher","first-page":"e11378","DOI":"10.1371\/journal.pone.0011378","volume":"5","author":"JE Zuniga","year":"2010","unstructured":"Zuniga JE, Hammill JT, Drory O, Nuss JE, Burnett JC, Gussio R, Wipf P, Bavari S, Brunger AT (2010) Iterative structure-based peptide-like inhibitor design against the botulinum neurotoxin serotype A. PLoS ONE 5:e11378","journal-title":"PLoS ONE"},{"key":"10_CR68","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1016\/j.str.2008.07.011","volume":"16","author":"JE Zuniga","year":"2008","unstructured":"Zuniga JE, Schmidt JJ, Fenn T, Burnett JC, Arac D, Gussio R, Stafford RG, Badie SS, Bavari S, Brunger AT (2008) A potent peptidomimetic inhibitor of botulinum neurotoxin serotype A has a very different conformation than SNAP-25 substrate. Structure (Camb) 16:1588\u20131597","journal-title":"Structure (Camb)"}],"container-title":["Current Topics in Microbiology and Immunology","Botulinum Neurotoxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-33570-9_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T06:05:26Z","timestamp":1710482726000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-642-33570-9_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"ISBN":["9783642335693","9783642335709"],"references-count":68,"aliases":["10.1007\/978-3-662-45790-0_10"],"URL":"https:\/\/doi.org\/10.1007\/978-3-642-33570-9_10","relation":{},"ISSN":["0070-217X"],"issn-type":[{"value":"0070-217X","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]},"assertion":[{"value":"14 December 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}